Veeda Clinical Research, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer

Phase 2
Terminated
Conditions
Breast Cancer
First Posted Date
2008-02-05
Last Posted Date
2012-05-11
Lead Sponsor
Veeda Oncology
Target Recruit Count
16
Registration Number
NCT00607438
Locations
🇺🇸

Veeda Oncology, Columbus, Ohio, United States

A Phase IV Trial of Cesametâ„¢ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting

Phase 4
Terminated
Conditions
Nausea and Vomiting
First Posted Date
2007-01-05
Last Posted Date
2010-12-02
Lead Sponsor
Veeda Oncology
Target Recruit Count
16
Registration Number
NCT00418678
Locations
🇺🇸

Veeda Oncology, Columbus, Ohio, United States

PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPC

Phase 2
Terminated
Conditions
Hormone Refractory Prostate Cancer
First Posted Date
2006-04-12
Last Posted Date
2012-05-11
Lead Sponsor
Veeda Oncology
Target Recruit Count
35
Registration Number
NCT00313482
Locations
🇺🇸

Veeda Oncology, Columbus, Ohio, United States

A Phase II Trial of Abraxaneâ„¢ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer

Phase 2
Completed
Conditions
Metastatic Breast Cancer
First Posted Date
2005-11-10
Last Posted Date
2012-05-11
Lead Sponsor
Veeda Oncology
Target Recruit Count
72
Registration Number
NCT00251472
Locations
🇺🇸

Veeda Oncology, Columbus, Ohio, United States

A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC

Phase 2
Completed
Conditions
Non-Small Cell Lung Cancer
First Posted Date
2005-11-10
Last Posted Date
2012-05-11
Lead Sponsor
Veeda Oncology
Target Recruit Count
69
Registration Number
NCT00251524
Locations
🇺🇸

Veeda Oncology, Columbus, Ohio, United States

A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer

Phase 2
Completed
Conditions
Non-Small Cell Lung Cancer
First Posted Date
2005-11-10
Last Posted Date
2012-05-11
Lead Sponsor
Veeda Oncology
Target Recruit Count
70
Registration Number
NCT00251446
Locations
🇺🇸

Veeda Oncology, Houston, Texas, United States

A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer

Phase 2
Completed
Conditions
Colorectal Cancer
First Posted Date
2005-11-10
Last Posted Date
2008-08-21
Lead Sponsor
Veeda Oncology
Target Recruit Count
82
Registration Number
NCT00251485
Locations
🇺🇸

Veeda Oncology, Houston, Texas, United States

A Phase II Trial of Trisenox Plus Thalomid as Treatment in Patients With Myelodysplastic Syndrome

Phase 2
Terminated
Conditions
Myelodysplastic Syndrome
First Posted Date
2005-11-10
Last Posted Date
2012-05-11
Lead Sponsor
Veeda Oncology
Target Recruit Count
60
Registration Number
NCT00251511
Locations
🇺🇸

Veeda Oncology, Houston, Texas, United States

Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer

Phase 2
Completed
Conditions
Carcinoma, Non-Small-Cell Lung
First Posted Date
2005-11-10
Last Posted Date
2008-08-21
Lead Sponsor
Veeda Oncology
Target Recruit Count
82
Registration Number
NCT00251498
Locations
🇺🇸

Veeda Oncology, Houston, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy